Market capitalization | $180.60m |
Enterprise Value | $176.03m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 5.50 |
P/S ratio (TTM) P/S ratio | 5.65 |
P/B ratio (TTM) P/B ratio | 10.18 |
Revenue growth (TTM) Revenue growth | 11.57% |
Revenue (TTM) Revenue | $31.99m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
5 Analysts have issued a Repro-Med Systems, Inc. forecast:
5 Analysts have issued a Repro-Med Systems, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 32 32 |
12%
12%
|
|
Gross Profit | 19 19 |
23%
23%
|
|
EBITDA | -6.15 -6.15 |
37%
37%
|
EBIT (Operating Income) EBIT | -7.05 -7.05 |
33%
33%
|
Net Profit | -12 -12 |
45%
45%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.
Head office | United States |
CEO | Linda Tharby |
Employees | 82 |
Founded | 1980 |
Website | www.korumedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.